In addition, SARS-CoV-2 is known to impede antigen presentation by downregulating the expression of major histocompatibility complex (MHC) class I and II molecules, which hampers the activation of T cell-mediated immune responses, further complicating the immune system’s ability to combat the infection (Mohammed et al., 2022) effectively. The gene discussed is HLA-C; the disease is infection.